NCT01996046: FDG PET/CT in Breast Cancer Bone Mets

NCT01996046
Breast Cancer Type: HR+ & HER2-negative
Hormone Mutations: ER+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: Female
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Bone
Additional Notes: Patient must have ER+ breast cancer
Exclusions: Patients with prior treatment of radiation or surgery to a significant percentage of bony metastatic sites
https://ClinicalTrials.gov/show/NCT01996046

Comments are closed.

Up ↑